• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Former SNN Exec Joseph DeVivo tapped for top spot at AngioDynamics

Former SNN Exec Joseph DeVivo tapped for top spot at AngioDynamics

August 16, 2011 By MassDevice staff

AngioDynamics

AngioDynamics Inc. (NSDQ:ANGO) named Joseph DeVivo as its new top executive, effective Sept. 7, 2011.

DeVivo, 44, was formerly president of the orthopedic division of Smith & Nephew plc (NYSE:SNN), until he was cut loose in early August as the British orthopedic maker reshuffled the deck to concentrate on emerging markets in Brazil, Russia, India and China.

DeVivo will replace interim CEO Scott Solano at the Latham, N.Y.-based maker of the NanoKnife. Solano, the company’s chief technology officer, had been running the company since the former CEO Jan Keltjens resigned in early June, after the company reported fourth quarter sales that missed the mark.

Company officials said Solano will return to his former position. DeVivo will be nominated for the company’s board of directors at AngioDynamics’ next annual meeting.

AngioDynamics officials said DeVivo was a highly sought after candidate for the position.

“Joe has been our top choice since we began our search,” AngioDynamics chairman Vincent Bucci said in a prepared release. “Smith & Nephew recently reported that its orthopedic business had the fastest growth rate of all its business segments again during its most recent quarter while continuing to drive share. We are thrilled to have recruited the architect of this growth.”

DeVivo takes over a company coming out of a tough quarter that saw AngioDynamics record a $752,000 net loss during the three-month period ended on May 31, reversing a $3.7 million profit. For the year, profits dove 33 percent on relatively flat sales.

In addition, the company has also been under a spotlight for allegedly over-zealous marketing of its NanoKnife system. The FDA accused AngioDynamics of making statements on its website promoting the use of the device beyond its approved indications early this year.

The appointment will also be a sort of homecoming for DeVivo, who was the former CEO of RITA Medical Systems, which AngioDynamics purchased in 2006. Officials said RITA’s products have formed much of AngioDynamics’ oncology/surgery division.

Filed Under: News Well, Oncology, Orthopedics Tagged With: AngioDynamics, Personnel Moves, Smith & Nephew

More recent news

  • Comphya raises CHF 7.5 million for neurostim to treat ED
  • Fujifilm launches intelligent automation features for digital radiography
  • Integer appoints former iRhythm CEO to board
  • MMI debuts robotic surgery instruments, digital surgery platform
  • Synchrony Medical wins FDA nod for airway clearance system

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy